GMO Product Platform
3695.TInformation & Communication
Filed as GMO Research, Inc (2022-08–2024-03), GMO Research & AI, Inc. (2024-05–2025-08), GMO Product Platform,Inc. (2026-08–2026-08)
Financials · Consolidated
| Fiscal year ended | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|---|
| Revenue | ¥6.8bn | ¥5.0bn | ¥5.1bn | ¥5.2bn | ¥4.1bn | ¥3.4bn |
| Operating income | ¥341m | ¥235m | ¥441m | ¥420m | ¥353m | — |
| Ordinary income | ¥323m | ¥249m | ¥428m | ¥458m | ¥385m | ¥241m |
| Net income (owners) | ¥156m | ¥183m | ¥307m | ¥356m | ¥274m | ¥176m |
| Total assets | ¥9.5bn | ¥3.0bn | ¥3.0bn | ¥3.1bn | ¥2.8bn | ¥2.2bn |
| Net assets / equity | ¥2.5bn | ¥2.1bn | ¥2.0bn | ¥1.9bn | ¥1.7bn | ¥1.5bn |
| Operating cash flow | ¥991m | ¥238m | ¥475m | ¥132m | ¥482m | ¥363m |
| EPS (basic) | ¥41.83 | ¥112.1 | ¥188.23 | ¥218.39 | ¥168.03 | ¥107.73 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 13
| Period | Form | Figures |
|---|---|---|
| 2026-01-01 → 2026-06-30 | Half-year | 67 figures · EDINET |
| 2025-01-01 → 2025-12-31 | Annual | 203 figures · EDINET |
| 2025-01-01 → 2025-06-30 | Half-year | 67 figures · EDINET |
| 2024-01-01 → 2024-12-31 | Annual | 205 figures · EDINET |
| 2024-01-01 → 2024-06-30 | Half-year | 69 figures · EDINET |
| 2024-01-01 → 2024-03-31 | Quarterly Q1 | 45 figures · EDINET |
| 2023-01-01 → 2023-12-31 | Annual | 207 figures · EDINET |
| 2023-01-01 → 2023-09-30 | Quarterly Q3 | 48 figures · EDINET |
| 2023-01-01 → 2023-06-30 | Quarterly Q2 | 72 figures · EDINET |
| 2023-01-01 → 2023-03-31 | Quarterly Q1 | 46 figures · EDINET |
| 2022-01-01 → 2022-12-31 | Annual | 207 figures · EDINET |
| 2022-01-01 → 2022-09-30 | Quarterly Q3 | 48 figures · EDINET |
| 2022-01-01 → 2022-06-30 | Quarterly Q2 | 72 figures · EDINET |
23 more reports are still being processed.